Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021
Steven G. Deeks(University of California, San Francisco), Josephine Nabukenya, Richard Jefferys(Utrecht University), Rosanne Lamplough(International AIDS Society), Zaza M. Ndhlovu(Ragon Institute of MGH, MIT and Harvard), Alex Schneider(University of North Carolina Health Care), Joel N. Blankson(Johns Hopkins University), Christina Antoniadi(Gladstone Institutes), Katharine J. Bar(California University of Pennsylvania), Marein de Jong(Aidsfonds), Paula M. Cannon(University of Southern California), Nancie M. Archin(University of North Carolina at Chapel Hill), Fernanda Heloise Côrtes(Fundação Oswaldo Cruz), Marein A.W.P. de Jong(Aidsfonds), Thumbi Ndung’u(Africa Health Research Institute), J. Víctor García(University of North Carolina at Chapel Hill), Kai Deng(Capital University), Ole S. Søgaard(Aarhus University Hospital), Zabrina L. Brumme(Simon Fraser University), Melannie Ott(IrsiCaixa), Jeremy Sugarman(Johns Hopkins Berman Institute of Bioethics), Gabriela Turk(Emory University), Mirko Paiardini(Oregon National Primate Research Center), Bonnie J. Howell(Johns Hopkins University), Sharon R. Lewin(Peter Doherty Institute), R. Brad Jones(Cornell University), Siegfried Schwarze(Imperial College London), Linos Vandekerckhove(Ghent University Hospital), Nicolas Chomont(Vaccine & Gene Therapy Institute of Florida), Caroline T. Tiemessen(University of the Witwatersrand), Ricardo Sobhie Diaz(Rockefeller University), Jan van Lunzen(Universidade Federal de São Paulo), Olivier Lambotte(Inserm), Frank Mardarelli, Aurelio Orta‐Resendiz(University of Pennsylvania), Rose Nabatanzi(ViiV Healthcare (United Kingdom)), Richard M. Dunham(University of North Carolina at Chapel Hill), Santiago Perez Patrigeon(Gilead Sciences (United States)), Susana Valente(Queen's University), Luke D. Jasenosky(National Cancer Institute), Monique Nijhuis(University of the Witwatersrand), Simon Collins(Ghent University Hospital)
Cited by 367
Related Papers
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
|Nature|2012|1.2k
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k
Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer
|Journal of Clinical Oncology|2010|1k
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|847